Showing results (301-310 of 372) with videos related to
Sort By:
Pageof 38
Genes & Development|November 3, 2007
Malignant astrocytic glioma: genetics, biology, and paths to treatmentFrank B Furnari, Tim Fenton, Robert M Bachoo, et al.Journal of Neuro-Oncology|July 24, 2012
Prospective, high-throughput molecular profiling of human gliomasAndrew S Chi, Tracy T Batchelor, Dora Dias-Santagata, et al.Neuro-Oncology|June 29, 2021
The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryDavid N Louis, Arie Perry, Pieter Wesseling, et al.Journal of the National Cancer Institute|October 17, 1998
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomasJ G Cairncross, K Ueki, M C Zlatescu, et al.Gene Therapy|September 25, 1998
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vectorU Herrlinger, C M Kramm, K S Aboody-Guterman, et al.Cancer Research|November 23, 2006
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entitiesElizabeth A Maher, Cameron Brennan, Patrick Y Wen, et al.Cancer Cell|June 28, 2002
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axisRobert M Bachoo, Elizabeth A Maher, Keith L Ligon, et al.Brain Pathology (Zurich, Switzerland)|April 18, 1998
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSLJ M Cobbers, M Wolter, J Reifenberger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatmentDaniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.Acta Neuropathologica|January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaGenevieve Schindler, David Capper, Jochen Meyer, et al.Pageof 38